Praxis Precision Medicines (PRAX) Net Equity Issued and Repurchased (2019 - 2026)
Praxis Precision Medicines (PRAX) posted Net Equity Issued and Repurchased of $621.2 million for Q1 2026, up 30.01% on a QoQ basis from $477.9 million in Q4 2025, and up 1031.49% year-over-year from $54.9 million in Q1 2025.
Powered by 
Analysis
Praxis Precision Medicines (PRAX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
Praxis Precision Medicines has reported Net Equity Issued and Repurchased for 8 years, with the latest figure at $621.2 million in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased rose 1031.49% year-over-year to $621.2 million in Q1 2026; TTM through Jun 2026 was $1.1 billion, a 1228.95% increase from a year earlier, with the FY2025 full-year figure at $567.1 million, up 50.18% from the prior year.
- Net Equity Issued and Repurchased was $621.2 million for Q1 2026 at Praxis Precision Medicines, up from $477.9 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $621.2 million in Q1 2026, with the low at -$4.3 million in Q4 2022.
- Average Net Equity Issued and Repurchased over 5 years is $125.3 million, with a median of $28.4 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Net Equity Issued and Repurchased slumped 6362.69% in 2022, then jumped 5655.56% in 2025.
- Over 5 years, Net Equity Issued and Repurchased stood at -$4.3 million in 2022, then surged by 1147.18% to $45.3 million in 2023, then slumped by 100.24% to -$108000.0 in 2024, then surged by 442555.56% to $477.9 million in 2025, then surged by 30.01% to $621.2 million in 2026.
- The last three Net Equity Issued and Repurchased figures came in at $621.2 million (Q1 2026), $477.9 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn | - |
| 10 | Praxis Precision Medicines | 8.34 Bn | 7.58 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 621.24 Mn |
| Dec 31, 2025 | 477.85 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 28.36 Mn |
| Mar 31, 2025 | 54.90 Mn |
| Sep 30, 2024 | -108,000.00 |
| Jun 30, 2024 | 216.10 Mn |
| Mar 31, 2024 | 161.65 Mn |
| Jun 30, 2023 | 45.34 Mn |
| Mar 31, 2023 | 18.10 Mn |
| Dec 31, 2022 | -4.33 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | -67,000.00 |
| Sep 30, 2021 | -96,000.00 |
| Jun 30, 2021 | 98.58 Mn |
| Sep 30, 2020 | 109.98 Mn |
| Dec 31, 2019 | 50.45 Mn |
API Access
Praxis Precision Medicines Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PRAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PRAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PRAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();